Skip to main content

Japanese enceph vacc sa14-14-2, inactivated Disease Interactions

There is 1 disease interaction with japanese enceph vacc sa14-14-2, inactivated.

Moderate

Japanese enceph vacc SA14-14-2, inactivated (applies to japanese enceph vacc sa14-14-2, inactivated) immunodeficiency

Moderate Potential Hazard, Moderate plausibility.

The use of japanese enceph vacc SA14-14-2, inactivated in immunocompromised individuals may have a diminished immune response to the agent. Close monitoring is recommended.

References

  1. "Product Information. Ixiaro (Japanese enceph vacc SA14-14-2, inactivated)." Valneva USA (2022):

Japanese enceph vacc sa14-14-2, inactivated drug interactions

There are 288 drug interactions with japanese enceph vacc sa14-14-2, inactivated.

Report options

Loading...
QR code containing a link to this page

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer